Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22,037,221
-
Total 13F shares
-
6,882,688
-
Share change
-
+50,723
-
Total reported value
-
$19,959,393
-
Price per share
-
$2.90
-
Number of holders
-
28
-
Value change
-
+$147,219
-
Number of buys
-
12
-
Number of sells
-
7
Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2023
As of 30 Jun 2023,
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,882,688 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Stonepine Capital Management, LLC, WASATCH ADVISORS LP, COWEN AND COMPANY, LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, VANGUARD GROUP INC, MORGAN STANLEY, PERKINS CAPITAL MANAGEMENT INC, UBS Group AG, and Nantahala Capital Management, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.